A share price of Kestra Medical Technologies Ltd [KMTS] is currently trading at $17.67, down -1.28%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The KMTS shares have gain 17.56% over the last week, with a monthly amount drifted -22.70%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Kestra Medical Technologies Ltd [NASDAQ: KMTS] stock has seen the most recent analyst activity on March 31, 2025, when Wolfe Research initiated its Outperform rating and assigned the stock a price target of $29. Previously, Wells Fargo started tracking the stock with Overweight rating on March 31, 2025, and set its price target to $28. On March 31, 2025, Stifel initiated with a Buy rating and assigned a price target of $28 on the stock. Piper Sandler started tracking the stock assigning a Overweight rating and suggested a price target of $27 on March 31, 2025. Goldman initiated its recommendation with a Neutral and recommended $24 as its price target on March 31, 2025. BofA Securities started tracking with a Buy rating for this stock on March 31, 2025, and assigned it a price target of $30.
Kestra Medical Technologies Ltd experienced fluctuations in its stock price throughout the past year between $14.15 and $26.15. Kestra Medical Technologies Ltd [NASDAQ: KMTS] shares were valued at $17.67 at the most recent close of the market.
Analyzing the KMTS fundamentals
Trailing Twelve Months sales for Kestra Medical Technologies Ltd [NASDAQ:KMTS] were 52.64M which represents 82.31% growth. Gross Profit Margin for this corporation currently stands at 0.26% with Operating Profit Margin at -1.82%, Pretax Profit Margin comes in at -1.96%, and Net Profit Margin reading is -1.96%. To continue investigating profitability, this company’s Return on Assets is posted at -0.61, Equity is 0.27 and Total Capital is -0.88. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-0.17.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 16.98 points at the first support level, and at 16.29 for the second support level. However, for the 1st resistance point, the stock is sitting at 18.27, and for the 2nd resistance point, it is at 18.87.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Kestra Medical Technologies Ltd [NASDAQ:KMTS] is 1.81. Also, the Quick Ratio is 1.65, while the Cash Ratio stands at 1.4. Considering the valuation of this stock, the price to sales ratio is 17.24.
